跳至主要内容
临床试验/NCT06616857
NCT06616857招募中不适用

Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis

Nemours Children's Clinic2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年2月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
Recruitment

研究概览

简要总结

The goal of this clinical trial is to help adolescents and young adults between the ages of 13-25 with Cystic Fibrosis (CF), medically stable, able to speak and read English, and are not experiencing a CF - related exacerbation, who are already active to remain, or gradually encourage them to increase their levels of physical activity

Participants will be asked to utilize a smartphone program, called NUDGE that we have developed. NUDGE is a chatbot with evidence-based features known to help teens make progress toward health goal:

  • Set and review goals
  • Self-monitor progress
  • Provide feedback on goal attainment
  • Revise future goals

详细描述

The goal of this study is to conduct a 6-month delayed treatment pilot Trial with adolescents and young adults (AYA) ages 13-25 with Cystic Fibrosis (CF) or a CF related disorder) to establish feasibility and obtain data necessary to inform a Phase III efficacy trial. AYAs 18 years-old and caregivers of AYAs 13-17 years-old will complete the informed consent process. AYAs 13-17 years-old will be asked to assent to participate in the study. After completion of the baseline study measures and return of actigraphy monitors, staff will notify AYAs of their randomized assignment. AYAs receiving NUDGE will then begin receiving intervention content for 6 months. AYAs randomized to control will receive NUDGE at the conclusion of the Month 3 study visit. Study visits will occur at Months 0, 3, and 6 with staff masked to treatment assignment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
13 Years 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 13-25 years old
  • Has a verified CF diagnosis or CF-related disorder
  • Medically stable (i.e., FEV1>30%, not experiencing a CF-related exacerbation)
  • Speaks and reads English

排除标准

  • Have a comorbidity limiting PA participation (e.g., neurological condition)
  • Have a significant cognitive impairment that interferes with study completion
  • Have any oxygen, CPAP or BiPAP requirement

研究组 & 干预措施

NUDGE

Experimental

干预措施: NUDGE (Behavioral)

Education

Active Comparator

干预措施: Education (Other)

结局指标

主要结局

Recruitment

时间窗: Baseline

Recruitment: Our recruitment goal is 30 AYAs with CF.

Retention

时间窗: 3-month

Retention: Our criterion for success is no more than 20% attrition.

Engagement

时间窗: 3-month

Engagement: We will be considered engagement a success if AYAs in NUDGE respond to an average of 4/7 (57%) messages each week during the first 3 months that a participant uses NUDGE.

Acceptability

时间窗: 3-month

Acceptability: We will consider NUDGE acceptable if users report a satisfaction rating of ≥3 (mostly satisfied) on our modified Client Satisfaction Questionnaire and rate it as usable as ≥70% of other computerized systems on the System Usability Scale. We will also be attentive to themes in relation to the barriers and facilitators of using NUDGE and its success in promoting PA in interviews.

次要结局

  • Actigraphy(Baseline, 3-month, and 6-month)
  • Lung Functioning(Baseline, 3-month, and 6-month)
  • CF Quality of Life(Baseline, 3-month, and 6-month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Fedele

Principal Research Scientist

Nemours Children's Clinic

研究点 (2)

Loading locations...

相似试验